The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 3,801–3,900 of 31,469
Cardiovascular Risk and Insulin Resistance in Childhood Cancer Survivors
Steinberger, J., Sinaiko, A. R., Kelly, A. S., Leisenring, W. M., Steffen, L. M., Goodman, P. J., Mulrooney, D. A., Dietz, A. C., Moran, A., Perkins, J. L., et al. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.08.018 · Cited by 85
Yoneda, M., Nozaki, Y., Endo, H., Mawatari, H., Iida, H., Fujita, K., Yoneda, K., Takahashi, H., Kirikoshi, H., Inamori, M., et al. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0771-y · Cited by 88
Visceral Adiposity Is Associated with Serum Retinol Binding Protein‐4 Levels in Healthy Women
Lee, J., Im, J., Lee, H. C., Shim, J., Youn, B., & Lee, D. (2007) · Obesity · doi:10.1038/oby.2007.264 · Cited by 86
Assessment of insulin secretion in relation to insulin resistance
Mari, A., Åhrén, B., & Pacini, G. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000171130.23441.59 · Cited by 89
Sebbagh, N., Cruciani‐Guglielmacci, C., Ouali, F., Berthault, M., Rouch, C., Sari, D. C., & Magnan, C. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.10.005 · Cited by 85
Comparison of Two Physical Activity Questionnaires in Obese Subjects: The NUGENOB Study
Téhard, B., Saris, W. H. M., Astrup, A. V., Martínez, J. A., Taylor, M. A., Barbe, P., Richterova, B., Guy-grand, B., SØRENSEN, T. I. A., & Oppert, J. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000177464.68521.3b · Cited by 87
Hoofnagle, A. N., Wu, M., Gosmanova, A. K., Becker, J. O., Wijsman, E. M., Brunzell, J. D., Kahn, S. E., Knopp, R. H., Lyons, T. J., & Heinecke, J. W. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.212894 · Cited by 87
Qi, Q., Bray, G. A., Hu, F. B., Sacks, F. M., & Qi, L. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.025270 · Cited by 88
Dietary antioxidant capacity is inversely associated with diabetes biomarkers: The ATTICA study
Ψαλτοπούλου, Θ., Panagiotakos, D. B., Pitsavos, C., Chrysochoou, C., Detopoulou, P., Skoumas, J., & Stefanadis, C. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.11.005 · Cited by 86
Ndisang, J. F., & Jadhav, A. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90783.2008 · Cited by 87
Breastfeeding and Atherosclerosis
Martin, R. M., Ebrahim, S. B. J., GRIFFIN, M. B., Smith, G. D., Nicolaides, A. N., Georgiou, N., Watson, S., Frankel, S., Holly, J. M. P., & Gunnell, D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000170129.20609.49 · Cited by 88
Romero-Aleshire, M. J., Diamond-Stanic, M. K., Hasty, A. H., Hoyer, P. B., & Brooks, H. L. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90762.2008 · Cited by 90
Obesity, Insulin Resistance, and Incident Small Vessel Disease on Magnetic Resonance Imaging
Dearborn, J. L., Schneider, A. L. C., Sharrett, A. R., Mosley, T. H., Bezerra, D. C., Knopman, D. S., Selvin, E., Jack, C. R., Coker, L. H., Alonso, Á., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.010060 · Cited by 90
Hirata, T., Tomita, K., Kawai, T., Yokoyama, H., Shimada, A., Kikuchi, M., Hirose, H., Ebinuma, H., Irie, J., Ojiro, K., et al. (2013) · International Journal of Endocrinology · doi:10.1155/2013/587140 · Cited by 87
Kong, L. C., Wuillemin, P.-H., Bastard, J., Sokolovska, N., Gougis, S., Fellahi, S., Darakhshan, F., Bonnefont‐Rousselot, D., Bittar, R., Dore, J. M., et al. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.058099 · Cited by 92
Insulin Resistance, Inflammation, and Blood Pressure Determine Vascular Dysfunction in CKD
Dogra, G. K., Irish, A. B., Chan, D. C., & Watts, G. F. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.08.008 · Cited by 87
Gerchman, F., Tong, J., Utzschneider, K. M., Zraika, S., Udayasankar, J., McNeely, M. J., Carr, D. B., Leonetti, D. L., Young, B. A., de Boer, I. H., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2508 · Cited by 88
Rosiglitazone Improves Exercise Capacity in Individuals With Type 2 Diabetes
Regensteiner, J. G., Bauer, T. A., & Reusch, J. E. B. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2877 · Cited by 87
Noh, H., Yu, M. R., Kim, H. J., Lee, J. H., Park, B., Wu, I., Matsumoto, M., & King, G. L. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.013 · Cited by 90
Houjeghani, S., Kheirouri, S., Faraji, E., & Jafarabadi, M. A. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.11.003 · Cited by 87
Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects
Wenyi, Z., Suzuki, S., Hirai, M., et al. (2003) · Diabetologia · doi:10.1007/s00125-003-1145-1 · Cited by 87
Woods, K. A., Helvoirt, M. V., Ong, K. K., Mohn, A., Lévy, J., de Zegher, F., & Dunger, D. B. (2002) · Pediatric Research · doi:10.1203/00006450-200201000-00014 · Cited by 87
Truncal Adiposity, Relative Growth Hormone Deficiency, and Cardiovascular Risk
Miller, K. K., Biller, B. M. K., Lipman, J. G., Bradwin, G., Rifai, N., & Klibanski, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0894 · Cited by 85
Weaver, J. U., Kopelman, P. G., & Hitman, G. A. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01461.x · Cited by 84
Mørkrid, K., Jenum, A. K., Sletner, L., Vårdal, M. H., Waage, C. W., Nakstad, B., Vangen, S., & Birkeland, K. I. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0452 · Cited by 83
Flock, M. R., Green, M. H., & Kris-Etherton, P. M. (2011) · Advances in Nutrition · doi:10.3945/an.111.000422 · Cited by 82
Dollerup, O. L., Trammell, S. A. J., Hartmann, B., Holst, J. J., Christensen, B., Møller, N., Gillum, M. P., Treebak, J. T., & Jessen, N. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01081 · Cited by 77
Ablation of XP-V gene causes adipose tissue senescence and metabolic abnormalities
Chen, Y.-W., Harris, R. A., Hatahet, Z., & Chou, K.-M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506954112 · Cited by 86
Jensterle, M., Kocjan, T., Kravos, N. A., Pfeifer, M., & Janez, A. (2015) · Endocrine Research · doi:10.3109/07435800.2014.966385 · Cited by 86
Osei, K., Rhinesmith, S., Gaillard, T., & Schuster, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030686 · Cited by 86
Relationship of hepatitis C virus infection with diabetes in the U.S. population
Ruhl, C. E., Menke, A., Cowie, C. C., & Everhart, J. E. (2014) · Hepatology · doi:10.1002/hep.27047 · Cited by 87
Ryu, O., Chung, W., Lee, S., Hong, K.-S., Choi, M. G., & Yoo, H. J. (2014) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.29.5.620 · Cited by 86
Metformin affects the circadian clock and metabolic rhythms in a tissue-specific manner
Barnea, M., Haviv, L., Gutman, R., Chapnik, N., Madar, Z., & Froy, O. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.08.005 · Cited by 86
Larsen, R. N., Kingwell, B. A., Robinson, C., Hammond, L. J., Cerin, E., Shaw, J. E., Healy, G. N., Hamilton, M. T., Owen, N. G., & Dunstan, D. W. (2015) · Clinical Science · doi:10.1042/cs20140790 · Cited by 87
Silva, H. E. D., Arendt, B. M., Noureldin, S. A., Therapondos, G., Guindi, M. M., & Allard, J. P. (2014) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.01.009 · Cited by 86
Phillips, C. M., Goumidi, L., Bertrais, S., Field, M. R., Ordovás, J. M., Cupples, L. A., Defoort, C., Lovegrove, J. A., Drevon, C. A., Blaak, E. E., et al. (2009) · Journal of Nutrition · doi:10.3945/jn.109.115329 · Cited by 87
Fan, P., Liu, H., Wang, X., Zhang, F., Song, Q., Li, Q., Wu, H., & Bai, H. (2010) · Human Reproduction · doi:10.1093/humrep/deq047 · Cited by 87
Maternal obesity modulates intracellular lipid turnover in the human term placenta
Hirschmugl, B., Desoyé, G., Catalano, P., Klymiuk, I., Scharnagl, H., Payr, S., Kitzinger, E., Schliefsteiner, C., Lang, U. E., Wadsack, C., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.188 · Cited by 86
Palma-Duran, S. A., Kontogianni, M. D., Vlassopoulos, A., Zhao, S., Margariti, A., Georgoulis, M., Papatheodoridis, G., & Combet, E. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.023 · Cited by 87
Oh, T. J., Moon, J. H., Choi, S. H., Lim, S. K., Park, K. S., Cho, N. H., & Jang, H. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01239 · Cited by 94
Luna‐Vital, D. A., Luzardo‐Ocampo, I., Cuéllar-Núñez, M. L., Loarca-Piña, G. F., & de Mejía, E. G. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108343 · Cited by 90
Hormonal Treatment and Cardiovascular Risk Profile in Transgender Adolescents
Klaver, M., de Mutsert, R., van der Loos, M. A. T. C., Wiepjes, C. M., Twisk, J. W. R., den Heijer, M., Rotteveel, J., & Klink, D. T. (2020) · PEDIATRICS · doi:10.1542/peds.2019-0741 · Cited by 86
Hasegawa, T., Iino, C., Endo, T., Mikami, K., Kimura, M., Sawada, N., Nakaji, S., & Fukuda, S. (2020) · Nutrients · doi:10.3390/nu12051450 · Cited by 91
Zhang, S., Mwiberi, S., Pickford, R., Breitner, S., Huth, C., Köenig, W., Rathmann, W., Herder, C., Roden, M., Cyrys, J., et al. (2021) · The Lancet Planetary Health · doi:10.1016/s2542-5196(20)30275-8 · Cited by 86
Petr, M. A., Alfaras, I., Krawcyzk, M., Bair, W.-N., Mitchell, S. J., Morrell, C. H., Studenski, S. A., Price, N. L., Fishbein, K. W., Spencer, R. G. S., et al. (2021) · eLife · doi:10.7554/elife.62952 · Cited by 87
Lv, L., Zhou, Y., Chen, X., Gong, L., Wu, J., Luo, W., Shen, Y., Han, S., Hu, J., Wang, Y., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s318255 · Cited by 86
Zhang, H., Ben, Y., Han, Y.-H., Zhang, Y., Li, Y., & Chen, X. (2021) · Environmental Research · doi:10.1016/j.envres.2021.112109 · Cited by 86
Prasad, R. B., Asplund, O., Shukla, S., Wagh, R. S. H., Kunte, P. S., Bhat, D., Parekh, M., Shah, M., Phatak, S. B., Käräjämäki, A., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05543-y · Cited by 85
Metabolic Obesity in People with Normal Body Weight (MONW)—Review of Diagnostic Criteria
Pluta, W. W., Dudzińska, W., & Lubkowska, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020624 · Cited by 97
d’Annunzio, G., Vanelli, M., Pistorio, A., Minuto, N., Bergamino, L., Iafusco, D., & Lorini, R. (2009) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 89
for the ANRS CO 13 HEPAVIH Study Group, Loko, M., Salmon, D., et al. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-303 · Cited by 86
Caumo, A., Perseghin, G., Brunani, A., & Luzi, L. (2006) · Diabetes Care · doi:10.2337/dc06-0070 · Cited by 86
Association Between Insulin Resistance and Development of Microalbuminuria in Type 2 Diabetes
Hsu, C., Chang, H., Huang, M., Hwang, S.-J., Yang, Y., Tai, T., Yang, H.-J., Chang, C., Chang, C.-J., Li, Y., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1718 · Cited by 86
Falkner, B. E., DeLoach, S. S., Keith, S. W., & Gidding, S. S. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.06.009 · Cited by 86
Strasser, B., Berger, K., & Fuchs, D. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0690-3 · Cited by 86
Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome
Hajamor, S., Després, J., Couillard, C., Lemieux, S., Tremblay, A., Prud’homme, D., & Tchernof, A. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00066-0 · Cited by 86
Appleton, D. J., Rand, J. S., & Sunvold, G. (2005) · Journal of Feline Medicine and Surgery · doi:10.1016/j.jfms.2004.12.002 · Cited by 86
Comparison of Hormone and Glucose Responses of Overweight Women to Barley and Oats
Behall, K. M., Scholfield, D. J., & Hallfrisch, J. G. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719464 · Cited by 86
Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro
Schmid, U., Stopper, H., Heidland, A., & Schupp, N. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.860 · Cited by 89
Associations between visceral adipose tissue, inflammation and sex steroid concentrations in men
Gautier, A., Bonnet, F., Dubois, S., Massart, C., Grosheny, C., Bachelot, A., Aubé, C., Balkau, B., & Ducluzeau, P. (2013) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04401.x · Cited by 91
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
Petta, S., Valenti, L. V. C., Marchesini, G., Marco, V. D., Licata, A., Cammà, C., Barcellona, M. R., Cabibi, D., Donati, B., Fracanzani, A. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074089 · Cited by 87
Paradoxical Preservation of Vascular Function in Severe Obesity
Biasucci, L. M., Graziani, F., Rizzello, V., Liuzzo, G., Guidone, C., Caterina, A. R. D., Brugaletta, S., Mingrone, G., & Crea, F. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.02.016 · Cited by 89
Teixeira, T. F. S., Grześkowiak, Ł., Salminen, S., Laitinen, K., Bressan, J., & Pelúzio, M. D. C. G. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.02.008 · Cited by 85
Colao, A., Pivonello, R., Auriemma, R. S., Galdiero, M., Savastano, S., & Lombardi, G. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0383 · Cited by 85
Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease
Döcke, S., Lock, J. F., Birkenfeld, A. L., Hoppe, S., Lieske, S., Rieger, A., Raschzok, N., Sauer, I. M., Florian, S., Osterhoff, M. A., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0112 · Cited by 87
André, P., Balkau, B., Born, C., Royer, B., Wilpart, E., Charles, M.-A. A., & Eschwège, É. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70229-x · Cited by 85
Taste perception in massively obese and in non-obese adolescents
Pasquet, P., Frelut, M. L., Simmen, B., Hladik, C. M., & Monneuse, M.-O. (2007) · International Journal of Pediatric Obesity · doi:10.1080/17477160701440521 · Cited by 85
Medina-Urrutia, A. X., Posadas‐Romero, C., Posadas‐Sánchez, R., Galarza, E. J., Villarreal-Molina, M. T., González-Salazar, M. D. C., Cardoso-Saldaña, G. C., Vargas‐Alarcón, G., Torres‐Tamayo, M., & Juárez-Rojas, J. G. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0184-5 · Cited by 86
Sluijs, I., Plantinga, Y., de Roos, B., Mennen, L. I., & Bots, M. L. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28192 · Cited by 87
Cupisti, S., Kajaia, N., Dittrich, R., Duezenli, H., Beckmann, M. W., & Mueller, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0515 · Cited by 86
Enhanced stimulant and metabolic effects of combined ephedrine and caffeine*1
HALLER, C. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.11.375 · Cited by 86
Thyroid function derangement and childhood obesity: an Italian experience
Grandone, A., Santoro, N., Coppola, F., Calabrò, P., Perrone, L., & del Giudice, E. M. (2010) · BMC Endocrine Disorders · doi:10.1186/1472-6823-10-8 · Cited by 84
Derosa, G., Cicero, A. F. G., Bertone, G., et al. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)80049-3 · Cited by 86
Mika Kivimaki, B., Smith, G. D., Juonala, M., Ferrie, J. E., Keltikangas‐Järvinen, L., Elovainio, M. J., Pulkki-Råback, L., Vahtera, J., Leino, M., Viikari, J. S. A., et al. (2005) · Heart · doi:10.1136/hrt.2005.067108 · Cited by 86
Sumida, Y., Yonei, Y., Tanaka, S., Mori, K., Kanemasa, K., Imai, S., Taketani, H., Hara, T., Seko, Y., Ishiba, H., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12408 · Cited by 87
Rafraf, M., Zemestani, M., & Jafarabadi, M. A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0170-x · Cited by 86
Zhang, F., Qiu, L., Xu, X., Liu, Z., Zhan, H., Tao, X., Shah, N. P., & Wei, H. (2016) · Journal of Dairy Science · doi:10.3168/jds.2016-11870 · Cited by 85
Gubern, C. (2006) · Diabetes · doi:10.2337/diabetes.55.1.216 · Cited by 86
Pardini, V. C., Victoria, I. M. N., Rocha, S. M. V., Andrade, D. G., Rocha, A. M., Pieroni, F. B., Milagres, G., Purisch, S., & Velho, G. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4567 · Cited by 86
Paolisso, G., Tagliamonte, M. R., Barbieri, M., Zito, G. A., Gambardella, A., Varricchio, G., Ragno, E., & Varricchio, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6258 · Cited by 86
Does Waist Circumference Add to the Predictive Power of the Body Mass Index for Coronary Risk?
Iwao, S., Iwao, N., Muller, D. C., Elahi, D., Shimokata, H., & Andres, R. (2001) · Obesity Research · doi:10.1038/oby.2001.93 · Cited by 86
Hukshorn, C. J., Westerterp‐Plantenga, M. S., & Saris, W. H. M. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.4.771 · Cited by 86
Comparisons of three different methods for defining sarcopenia: an aspect of cardiometabolic risk
Kim, T. N., Park, M. S., Lee, E. J., Chung, H. S., Yoo, H. J., Kang, H. J., Song, W., Baik, S. H., & Choi, K. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-06831-7 · Cited by 86
Catta-Preta, M., Martins, M. A., Cunha Brunini, T. M., Mendes-Ribeiro, A. C., Mandarim-de-Lacerda, C. A., & Aguila, M. B. (2012) · Nutrition · doi:10.1016/j.nut.2011.05.011 · Cited by 83
Kelly, A., Dougherty, S., Cucchiara, A., Marcus, C. L., & Brooks, L. J. (2010) · SLEEP · doi:10.1093/sleep/33.9.1185 · Cited by 85
Succurro, E., Andreozzi, F., Marini, M. A., Lauro, R., Hribal, M. L., Perticone, F., & Sesti, G. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.12.011 · Cited by 85
Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes
Grădinaru, D., Borșa, C., Ionescu, C., & Margina, D. M. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.03.034 · Cited by 88
Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery
Ebert, T., Stepan, H., Schrey-Petersen, S., Kralisch, S., Hindricks, J., Hopf, L., Platz, M., Lössner, U., Jeßnitzer, B., Drewlo, S., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.11.009 · Cited by 86
Grasso, A., Malfatti, F., Leo, P. D., Martines, H., Fabris, P., Toscanini, F., Anselmo, M., & Menardo, G. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.07.008 · Cited by 85
Ross, A. C., Judd, S. E., Kumari, M., Hileman, C. O., Storer, N. J., Labbato, D. E., Tangpricha, V., & McComsey, G. A. (2010) · Antiviral Therapy · doi:10.3851/imp1784 · Cited by 85
Mostafalou, S., Baeeri, M., Bahadar, H., Soltany‐Rezaee‐Rad, M., Gholami, M., & Abdollahi, M. R. (2014) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2014.11.001 · Cited by 86
Wang, Y., Liu, H., Fan, P., Bai, H., Zhang, J., & Zhang, F. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0986 · Cited by 86
Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials
Zheng, Y., Ceglarek, U., Huang, T., Li, L., Rood, J. C., Ryan, D. H., Bray, G. A., Sacks, F. M., Schwarzfuchs, D., Thiery, J., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.117689 · Cited by 89
Dales, R., Kauri, L. M., & Cakmak, S. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.09.009 · Cited by 85
High-intensity Interval Training Frequency: Cardiometabolic Effects and Quality of Life
Stavrinou, P. S., Bogdanis, G. C., Giannaki, C. D., Terzis, G. D., & Hadjicharalambous, M. (2018) · International Journal of Sports Medicine · doi:10.1055/s-0043-125074 · Cited by 90
El‐Aal, A. A., Abdelghffar, E. A. R., Ghali, A. S. A., Zughbur, M. R., & Sirdah, M. M. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.013 · Cited by 85
Park, C., Yi, Y., Do, J. G., Lee, Y., & Yoon, K. J. (2018) · Medicine · doi:10.1097/md.0000000000012281 · Cited by 89
Son, J. S., Liu, X., Tian, Q., Zhao, L., Chen, Y., Hu, Y., Chae, S. A., de Avila, J. M., Zhu, M. J., & Du, . (2019) · The Journal of Physiology · doi:10.1113/jp277698 · Cited by 86
Hu, T., Wen, P., Shen, W., Liu, F., Li, Q., Erna, L., Liao, S., Wu, H., & Zou, Y. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b00205 · Cited by 88
Higashioka, M., Sakata, S., Honda, T., Hata, J., Yoshida, D., Hirakawa, Y., Shibata, M., Gotō, K., Kitazono, T., Osawa, H., et al. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.51961 · Cited by 88
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
